Propulsid Warning (Health/Medications)
fda.gov
Description: Notification of important changes in the U.S. FDA Propulsid labeling to reflect new... safety information, including recommendations for performing diagnostics tests prior to any use. small(January 24, 2000)small DESCRIBE CONTENTS
Specializes in: propulsid adverse event postmarketing surveillance adverse reactions medwatch fda medical product safety...

Cylert Letter to Health Professionals FDA (Health/Medications)
fda.gov
Description: Reproduction of warning letter sent by Abbott Labs to Health Professionals regarding... potential for hepatotoxicity with Cylert. Includes link to patient informationconsent form. Cylert (pemoline)recommendations for liver function monitoring
Specializes in: cylert pemoline liver function monitoring postmarketing surveillance adverse reactions medwatch fda medical product safety...